<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Window to the future</title>
	<atom:link href="http://www.fabricegrinda.com/interesting-articles/window-to-the-future/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.fabricegrinda.com/interesting-articles/window-to-the-future/</link>
	<description></description>
	<lastBuildDate>Wed, 08 Feb 2012 17:46:16 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
	<item>
		<title>By: sumon</title>
		<link>http://www.fabricegrinda.com/interesting-articles/window-to-the-future/comment-page-1/#comment-298</link>
		<dc:creator>sumon</dc:creator>
		<pubDate>Mon, 28 Aug 2006 21:06:37 +0000</pubDate>
		<guid isPermaLink="false">http://www.fabricegrinda.com/?p=93#comment-298</guid>
		<description>No, but the &quot;Singularity is Near&quot; definately appears to be required reading.

On the research end in Biotech, our knowledge is definately maturing rapidly regarding the molecular basis of a number of infectious diseases and more established human disease. I&#039;m currently in Malaria Vaccine research which is rapidly assimilating vast insights from &quot;post genomic&quot; information. 

Over the next few years will our insights get more interesting and coupled with the pace of change in nanotechnology and quantum electronics the first convergence applications which will make significant impact will be in medical diagnostics. These will include, nanosensors for cancer, infectious diseases of viral and bacterial origin.

These sorts of companies will require both advances in the biology before any significant R&amp;D can be invested. There is an interesting Stanford company called Theranos (http://www.theranos.com/solutions.html) which is indicative of the first generation of these &quot;convergence&quot; applications. There may be a few years left until everything is mature in that industry but at least it gives time to focus on the second dot com wave first ;)</description>
		<content:encoded><![CDATA[<p>No, but the &#8220;Singularity is Near&#8221; definately appears to be required reading.</p>
<p>On the research end in Biotech, our knowledge is definately maturing rapidly regarding the molecular basis of a number of infectious diseases and more established human disease. I&#8217;m currently in Malaria Vaccine research which is rapidly assimilating vast insights from &#8220;post genomic&#8221; information. </p>
<p>Over the next few years will our insights get more interesting and coupled with the pace of change in nanotechnology and quantum electronics the first convergence applications which will make significant impact will be in medical diagnostics. These will include, nanosensors for cancer, infectious diseases of viral and bacterial origin.</p>
<p>These sorts of companies will require both advances in the biology before any significant R&amp;D can be invested. There is an interesting Stanford company called Theranos (<a href="http://www.theranos.com/solutions.html" rel="nofollow">http://www.theranos.com/solutions.html</a>) which is indicative of the first generation of these &#8220;convergence&#8221; applications. There may be a few years left until everything is mature in that industry but at least it gives time to focus on the second dot com wave first ;)</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Fabrice Grinda</title>
		<link>http://www.fabricegrinda.com/interesting-articles/window-to-the-future/comment-page-1/#comment-295</link>
		<dc:creator>Fabrice Grinda</dc:creator>
		<pubDate>Mon, 28 Aug 2006 13:07:42 +0000</pubDate>
		<guid isPermaLink="false">http://www.fabricegrinda.com/?p=93#comment-295</guid>
		<description>Likewise - though biotech is still moving slower than I would like. Have you read: &quot;The Singularity is Near&quot;?</description>
		<content:encoded><![CDATA[<p>Likewise &#8211; though biotech is still moving slower than I would like. Have you read: &#8220;The Singularity is Near&#8221;?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: sumon</title>
		<link>http://www.fabricegrinda.com/interesting-articles/window-to-the-future/comment-page-1/#comment-294</link>
		<dc:creator>sumon</dc:creator>
		<pubDate>Mon, 28 Aug 2006 13:04:41 +0000</pubDate>
		<guid isPermaLink="false">http://www.fabricegrinda.com/?p=93#comment-294</guid>
		<description>Fabrice,

Great stuff. What really excites me at the moment is the exponential growth of knowledge in the biosciences, coupled with advances in nanotechnology, quantum computing, and electronics. It is this convergence between biological and physical scientists which will yield tremendous opportunity and the next great technical boom.

This is what i&#039;m watching as an entrepreneur: internet now, but excited by this convergence in the long run.</description>
		<content:encoded><![CDATA[<p>Fabrice,</p>
<p>Great stuff. What really excites me at the moment is the exponential growth of knowledge in the biosciences, coupled with advances in nanotechnology, quantum computing, and electronics. It is this convergence between biological and physical scientists which will yield tremendous opportunity and the next great technical boom.</p>
<p>This is what i&#8217;m watching as an entrepreneur: internet now, but excited by this convergence in the long run.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

